References
- https://www.cdc.gov/mmwr/volumes/70/wr/mm7015a1.htm
- Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatr. 2021;26(1):218–2. doi:10.1038/s41380-020-0661-4.
- Aguilera-Lizarraga J, Hussein H, Boeckxstaens GE. Immune activation in irritable bowel syndrome: what is the evidence? Nat Rev Immunol. 2022;22(11):674–686. doi:10.1038/s41577-022-00700-9.
- De Palma G, Shimbori C, Reed DE, Yu Y, Rabbia V, Lu J, Jimenez-Vargas N, Sessenwein J, Lopez-Lopez C, Pigrau M. et al. Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice. Sci Transl Med. 2022;14(655):eabj1895. doi:10.1126/scitranslmed.abj1895.
- Verdú EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006 Feb;55(2):182–190. doi:10.1136/gut.2005.066100.
- Pujo J, De Palma G, Lu J, Galipeau HJ, Surette MG, Collins SM, Bercik P. Gut microbiota modulates visceral sensitivity through calcitonin gene-related peptide (CGRP) production. Gut Microbes. 2023;15(1):2188874. doi:10.1080/19490976.2023.2188874.
- De Palma G, Reed DE, Bercik P. Diet–microbial cross–talk underlying increased visceral perception. Gut Microbes. 2023;15(1):2166780. doi:10.1080/19490976.2023.2166780.
- Caminero A, Guzman M, Libertucci J, Lomax AE. The emerging roles of bacterial proteases in intestinal diseases. Gut Microbes. 2023;15(1):2181922. doi:10.1080/19490976.2023.2181922.
- van Thiel IAM, de Jonge WJ, van den Wijngaard RM. Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain. Gut Microbes. 2023;15(1):2168992. doi:10.1080/19490976.2023.2168992.
- Botschuijver S, Roeselers G, Levin E, Jonkers DM, Welting O, Heinsbroek SEM, de Weerd HH, Boekhout T, Fornai M, Masclee AA. et al. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats. Gastroenterology. 2017;153(4):1026–1039. doi:10.1053/j.gastro.2017.06.004.
- Shin A, Kashyap PC. Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead. Gut Microbes. 2023;15(1):2195792. doi:10.1080/19490976.2023.2195792.